Startup | February 27, 2024
Pfizer joins hands with NIPER (Ahmedabad) to support Healthcare Innovation in India
Pfizer INDovation program partners with NIPER Ahmedabad to incubate healthcare startups
Pfizer INDovation program partners with NIPER Ahmedabad to incubate healthcare startups
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication
The US $600 million acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients in Asia Pacific, Middle East and Africa
The aim is to strengthen industry-academia cooperation
The Institute is catering the health needs of the surrounding population with ever-increasing OPD every year along with special OPDs like mother & Child OPD, and LSD clinic
8th Edition of the event to promote India as a manufacturing hub of quality medical products in the Pharmaceutical and Medical Devices Sector
The two-day event focused on the multi-faceted relationship of clinical research stakeholders and looked at bridging the academic and clinical research gap.
An outlay of Rs. 1,500 crore has been approved for strengthening/ up-gradation of these NIPERs for the period 2021-22 to 2025-26.
The department will soon release a policy to catalyze research & development and innovation in the pharma- Medtech sector in India
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)